The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Oct. 01, 2019

Filed:

Aug. 14, 2013
Applicant:

University of Washington Through Its Center for Commercialization, Seattle, WA (US);

Inventors:

Neil Owen, Seattle, WA (US);

Michael Bailey, Seattle, WA (US);

Oleg Sapozhinikov, Seattle, WA (US);

Assignee:

University of Washington, Seattle, WA (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61B 17/22 (2006.01); A61B 7/00 (2006.01); G06T 7/00 (2017.01); A61B 17/225 (2006.01); G10K 11/35 (2006.01); A61B 8/08 (2006.01); A61N 7/02 (2006.01); A61B 5/05 (2006.01); A61B 5/06 (2006.01); A61B 8/00 (2006.01); A61B 5/00 (2006.01); A61B 7/04 (2006.01); A61B 8/13 (2006.01); A61N 7/00 (2006.01); G10K 15/04 (2006.01);
U.S. Cl.
CPC ...
A61B 17/22004 (2013.01); A61B 5/05 (2013.01); A61B 5/06 (2013.01); A61B 5/4848 (2013.01); A61B 7/00 (2013.01); A61B 7/04 (2013.01); A61B 8/00 (2013.01); A61B 8/0833 (2013.01); A61B 8/13 (2013.01); A61B 17/225 (2013.01); A61B 17/22012 (2013.01); A61B 17/2256 (2013.01); A61N 7/00 (2013.01); A61N 7/02 (2013.01); A61N 7/022 (2013.01); G06T 7/0012 (2013.01); G06T 7/0016 (2013.01); G10K 11/35 (2013.01); A61B 8/085 (2013.01); A61B 17/22029 (2013.01); A61B 17/2255 (2013.01); A61B 2017/22011 (2013.01); A61N 2007/0052 (2013.01); G10K 15/04 (2013.01);
Abstract

During shock wave therapy, a determination is made that a kidney stone has begun to fracture, and then a progress of its fragmentation is assessed. This determination can reduce the number of shock waves used to disintegrate kidney stones, and thereby reduce dose-dependent tissue damage. The identification of fracture is possible through the detection and analysis of resonant acoustic scattering, which is the radiation caused by reverberations within a stone particle that is struck by a shock wave. The scattering frequency can provide both an indication that the kidney stone has fragmented, and an indication of the relative sizes of the fragments. Related concepts employ displacement measurements of kidney stones/fragments to provide both an indication that the kidney stone has fragmented, and an indication of the relative sizes of the fragments. Such techniques can be combined with vibro-acoustography based gating that better targets the stone.


Find Patent Forward Citations

Loading…